These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12409216)

  • 21. Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda.
    Yon L; Feuilloley M; Chartrel N; Arimura A; Conlon JM; Fournier A; Vaudry H
    J Comp Neurol; 1992 Oct; 324(4):485-9. PubMed ID: 1331206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactive neuronal elements in rat hypothalamus and median eminence with special reference to morphological background of its effect on anterior pituitary--light and electron microscopic immunocytochemistry.
    Tamada Y; Tanaka M; Ichitani Y; Okamura H; Yanaihara N; Ibata Y
    Neurosci Lett; 1994 Oct; 180(2):105-8. PubMed ID: 7700560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenylate cyclase-activating polypeptide triggers dual transduction signaling in CATH.a cells and transcriptionally activates tyrosine hydroxylase and c-fos expression.
    Muller A; Monnier D; Rene F; Larmet Y; Koch B; Loeffler JP
    J Neurochem; 1997 Apr; 68(4):1696-704. PubMed ID: 9084443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat.
    Légrádi G; Hannibal J; Lechan RM
    Neurosci Lett; 1998 May; 246(3):145-8. PubMed ID: 9792613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements.
    Meister B; Hökfelt T; Tsuruo Y; Hemmings H; Ouimet C; Greengard P; Goldstein M
    Neuroscience; 1988 Nov; 27(2):607-22. PubMed ID: 2905789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study.
    Hannibal J
    J Comp Neurol; 2002 Nov; 453(4):389-417. PubMed ID: 12389210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons.
    Girard BM; Keller ET; Schutz KC; May V; Braas KM
    Regul Pept; 2004 Dec; 123(1-3):107-16. PubMed ID: 15518900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light and electron microscopic studies of pituitary adenylate cyclase-activating peptide (PACAP)--immunoreactive neurons in the enteric nervous system of rat small and large intestine.
    Nagahama M; Tsuzuki M; Mochizuki T; Iguchi K; Kuwahara A
    Anat Embryol (Berl); 1998 Nov; 198(5):341-52. PubMed ID: 9801056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
    Takei N; Skoglösa Y; Lindholm D
    J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in pituitary adenylate cyclase activating polypeptide expression in urinary bladder pathways after spinal cord injury.
    Zvarova K; Dunleavy JD; Vizzard MA
    Exp Neurol; 2005 Mar; 192(1):46-59. PubMed ID: 15698618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in autonomic regulatory areas of the rat medulla oblongata.
    Légrádi G; Shioda S; Arimura A
    Neurosci Lett; 1994 Aug; 176(2):193-6. PubMed ID: 7830945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain.
    Walaas SI; Greengard P
    J Neurosci; 1984 Jan; 4(1):84-98. PubMed ID: 6319627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus.
    Gaszner B; Kormos V; Kozicz T; Hashimoto H; Reglodi D; Helyes Z
    Neuroscience; 2012 Jan; 202():283-99. PubMed ID: 22178610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion.
    Lutz-Bucher B; Monnier D; Koch B
    Neuroendocrinology; 1996 Aug; 64(2):153-61. PubMed ID: 8857610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptide potentiation of Ca2+ entry via protein kinase C and A pathways in melanotrophs of the pituitary pars intermedia of rats.
    Tanaka K; Shibuya I; Harayama N; Nomura M; Kabashima N; Ueta Y; Yamashita H
    Endocrinology; 1997 Oct; 138(10):4086-95. PubMed ID: 9322916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen.
    Langley KC; Bergson C; Greengard P; Ouimet CC
    Neuroscience; 1997 Jun; 78(4):977-83. PubMed ID: 9174066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
    D'Agata V; Cavallaro S; Stivala F; Canonico PL
    Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain.
    Peeters K; Gerets HH; Arckens L; Vandesande F
    J Comp Neurol; 2000 Jul; 423(1):66-82. PubMed ID: 10861537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation.
    Kirchgessner AL; Liu MT
    Anat Rec; 2001 Jan; 262(1):91-100. PubMed ID: 11146432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.